Boyle Scott N sold CCCC
February 14, 2026 · Form 4 insider transaction
Boyle Scott N sold 7,269 shares of C4 Therapeutics, Inc. at $1.89 per share, a transaction worth $13.7K. The trade was recorded as shares withheld for taxes and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Disposed (sell-side)
Shares
7,269
Price
$1.89
Total value
$13.7K
InsiderBoyle Scott N
Role—
CompanyC4 Therapeutics, Inc. (CCCC)
SecurityCommon Stock
Transaction codeF: Shares withheld for taxes
Transaction dateFebruary 14, 2026
Filing dateFebruary 18, 2026
Shares owned after298,801
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Reflects the acquisition of shares of Common Stock upon vesting of previously disclosed grants of RSUs. The grants of RSUs were initially reported in Table I of the Forms 4 filed by the Reporting Person on February 15, 2023, February 14, 2024 and February 18, 2025.